PHYSICIAN SCIENTIST LEADERSHIP POSITION IN EARLY PHASE CANCER CLINICAL TRIALS

The University of New Mexico Cancer Center (UNMCC) and the Department of Internal Medicine, Division of Hematology/Oncology at the UNM School of Medicine invite physicians and physician scientists with experience and expertise in experimental therapeutics, the development of novel targeted cancer therapies, and the design and conduct of early phase human cancer clinical trials. The successful applicant will have training, experience, and expertise in early phase clinical trials (first-in-human, phase zero, and phase I) and will be expected to develop an Early Phase Clinical Trial Program at the UNMCC in both hematologic malignancies and solid tumors, with an emphasis on rapid and informative translation from the bench-to-bedside-and-back with reagents (drug candidates, laboratory tests, or experimental devices) discovered and developed in concert with the UNMCC Research Programs. The UNMCC has an integrated discovery operation involving drug repurposing, ligand-directed targeting, personalized genomics, and biotechnology/nanotechnology. Superb collaborative opportunities exist with the UNMCC Consortium partners in high-end technology and advanced material or computer sciences (at Sandia and Los Alamos National Laboratories) and GLP toxicology (Lovelace Respiratory Research Institute). Knowledge and experience of the biotechnology start-up environment and pharmaceutical industry landscape is desired. Significant resources, including a comprehensive start-up package and endowed positions, are available. This is an Open Rank, Open Track position. Faculty rank and appointment will be commensurate with accomplishments.

Minimum qualifications include: 1) M.D. or MD/PhD degree with board certification in Internal Medicine; 2) board certification/eligibility in Medical Oncology and/or Hematology; 3) experience and/or medical oncology fellowship training in the design and conduct of early clinical trials and investigator-initiated clinical trials; 4) understanding of and/or experience in the NIH/NCI clinical trials system, biotechnology start-up environment, and pharmaceutical industry; and 5) must be eligible to work in the U.S.; this is not a J-1 Visa Opportunity. Preferred qualifications include: 1) experience in clinical and translational research at the level of Assistant or Associate Professor; 2) experience in clinical trial regulatory requirements and affairs; 3) experience in resident/fellow education.
To apply and view the complete description, please access Posting #0824861 at: https://unmjobs.unm.edu/.
Complete applications will include a cover letter, curriculum vitae, and the names of three references with mailing address, phone numbers and email address.
For all inquiries or questions, please contact:
Search Chair: Dr. Wadih Arap, MD, PhD, UNMCC Deputy Director and Chief of Hematology/Oncology at: warap@salud.unm.edu or (505) 925-0479, or, Search Coordinator: Denise Osborne at: dosborne@salud.unm.edu or (505) 925-0415.
Criminal records policy link: http://www.unm.edu/~brpm/r67.htm

University of New Mexico is an Equal Employment Opportunity/Affirmative Action Employer/Educator

The University of New Mexico Cancer Center (cancer.unm.edu) is one of the nation’s 68 premier National Cancer Institute-designated Cancer Centers and is the Official Cancer Center of New Mexico. Its 102 board-certified oncology physicians and 132 research scientists, recruited from leading institutions nationwide, form the region’s largest and most experienced team of cancer specialists. The outstanding physician team represents several Academic Disciplines and uses a multidisciplinary treatment approach. The vibrant team of basic, clinical and translational scientists, supported by $77 million in annual research funding, collaborate within four research programs: Cancer Drug Discovery & Targeted Delivery; Cancer Genetics, Epigenetics, & Genomics; Cancer Cell Biology & Signaling; and, Cancer Control & Disparities. The UNM Cancer Center’s statewide cancer clinical trials network offers over 175 therapeutic clinical trials. The UNM Cancer Center also houses one of 10 NIH-funded Centers for Systems Biology and an NCI Nanotechnology Alliance-funded program to develop novel nanocarriers for targeted delivery of cancer therapeutics and imaging agents

Direct Employer

1 University of New Mexico
MSC 07-4025
Albuquerque, NM 87131